- Joined
- Feb 26, 2014
- Messages
- 60
- Reaction score
- 4
- Points
- 4,591
My "suboxone patients" are really no different than my "zoloft patients" or my "effexor patients"--which is to say that suboxone is just one tool I use in my outpatient arsenal. I don't make a big deal of my suboxone practice--I monitor and adjust for response, ask about lifestyle issues, just as with other meds. I have 20 min per pt scheduled for rechecks. Newer starts I try to see at least q 2 weeks, more stable folks q 1-3 months.Do any of you work with suboxone patients? How long are your visits approximately?
My "suboxone patients" are really no different than my "zoloft patients" or my "effexor patients"--which is to say that suboxone is just one tool I use in my outpatient arsenal. I don't make a big deal of my suboxone practice--I monitor and adjust for response, ask about lifestyle issues, just as with other meds. I have 20 min per pt scheduled for rechecks. Newer starts I try to see at least q 2 weeks, more stable folks q 1-3 months.
Only from where you sit. Don't confuse signs with symptoms. Withdrawal is much more experiential painful and debilitating than the flu.Why do the patients fear withdrawal so much? It's like horrible flu.
So is addiction.Which suggests my next question--How long is the course of treatment for suboxone specifically in real life? The literature always talks about timely tapers. But in practice it seemed vaguely indefinite.
Only from where you sit. Don't confuse signs with symptoms. Withdrawal is much more experiential painful and debilitating than the flu.
So is addiction.
Everyone has their own philosophy in opiate replacement therapy. Personally, a lot more patients die, lose quality of life, or lose functionality from ending suboxone too soon than too late. Docs invariably seem to think addiction patients are doing better than they are. I treat the addiction very seriously and move slow.
This isn't an opiate thing either. I'm also cautious with ending nicotine replacement therapy too...
I have a suboxone patient question too.
Why do the patients fear withdrawal so much? It's like horrible flu. But suboxone patients are convinced they'll die without it.
Because most opiate addicted patients have limited ability to cope with day to day reality, and have limited ability to cope with feeling uncomfortable. for these patients experiencing horrible flu is excrutiatingly intolerable. especially because it is entirely avoidable with continued opiate use.
My "suboxone patients" are really no different than my "zoloft patients" or my "effexor patients"--which is to say that suboxone is just one tool I use in my outpatient arsenal. I don't make a big deal of my suboxone practice--I monitor and adjust for response, ask about lifestyle issues, just as with other meds. I have 20 min per pt scheduled for rechecks. Newer starts I try to see at least q 2 weeks, more stable folks q 1-3 months.
Good points, certainly. I should have also specified that I have barely a dozen such patients currently, only one younger than 30, and average age is >50. All except the youngest were over-users/abusers of prescription pain meds, not heroin.As an Addiction Psychiatry fellow (with almost 3 years experience prescribing buprenorphine now) I would start out seeing a patient weekly and would never see a patient less than monthly regardless of length of sobriety. Any "dirty" urine or indication of relapse would immediately necessitate increasing frequency to weekly visits again. And, of course, every visit has to have a urine drug screen. Also no refills on any scripts. The above is the best methodology to improve success and minimize diversion in my opinion.
Out of curiosity, do you have the same monthly visits with people not on suboxone? For folks on naltrexone, disulfram, etc.? I'm curious if q4 weeks is your standard for folks in the acute-to-maintenance phase of pharmacotherapy for addiction or only for suboxone out of fear of diversion.As an Addiction Psychiatry fellow (with almost 3 years experience prescribing buprenorphine now) I would start out seeing a patient weekly and would never see a patient less than monthly regardless of length of sobriety.
Out of curiosity, do you have the same monthly visits with people not on suboxone? For folks on naltrexone, disulfram, etc.? I'm curious if q4 weeks is your standard for folks in the acute-to-maintenance phase of pharmacotherapy for addiction or only for suboxone out of fear of diversion.
In general, I would recommend at least monthly visits with frequent monitoring (UDS, etc.) for patients with addictions due to the nature of the disease. Specifically, Vivitrol (naltrexone depot injection) is given monthly so would obviously require at least monthly visits. Oral medications for Alcohol Use Disorder (FDA approved: naltrexone, acamprosate, disulfiram & off-label use: Topamax, gabapentin, etc.) can be given more flexibility in terms of frequency of visits if the patient is very stable and has established sobriety (years, etc.). Due to the diversion risk of buprenoprhine and the significant mortality/morbidity rate associated with Opioid Use Disorder I would recommend the visit frequency I mentioned in my first post (initially weekly and never more than monthly with strict monitoring & no refills).
being fda approved is one thing; actual evidence that it is a good medication is another. The overall data(and not just cherry picking one direction) for something like acamprosate is truly hideous.
that said, a serious question for ORT(which in some cases I do believe in): if you're practicing on your own and not plugged into a larger system or recovery center/unit, how does one do and handle the suboxone uds? Do you just buy your own dipstic uds and send any + opiate out for further testing through labcorp or something?
This.Because most opiate addicted patients have limited ability to cope with day to day reality, and have limited ability to cope with feeling uncomfortable. for these patients experiencing horrible flu is excrutiatingly intolerable. especially because it is entirely avoidable with continued opiate use.
One other question. Is it your perspective that patients with substance abuse disorders need medication treatment indefinitely? That has not been my experience so am curious about that.In general, I would recommend at least monthly visits with frequent monitoring (UDS, etc.) for patients with addictions due to the nature of the disease. Specifically, Vivitrol (naltrexone depot injection) is given monthly so would obviously require at least monthly visits. Oral medications for Alcohol Use Disorder (FDA approved: naltrexone, acamprosate, disulfiram & off-label use: Topamax, gabapentin, etc.) can be given more flexibility in terms of frequency of visits if the patient is very stable and has established sobriety (years, etc.). Due to the diversion risk of buprenoprhine and the significant mortality/morbidity rate associated with Opioid Use Disorder I would recommend the visit frequency I mentioned in my first post (initially weekly and never more than monthly with strict monitoring & no refills).
One other question. Is it your perspective that patients with substance abuse disorders need medication treatment indefinitely? That has not been my experience so am curious about that.